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Background: The efficacy of a slow-release insecticidal and repellent collar containing 10% imidacloprid and 4.5%
flumethrin (Seresto, Bayer Animal Health) in preventing Leishmania infantum infection was evaluated in a large
population of dogs living in a hyper-endemic area of Sicily (Italy).
Methods: A total of 219 dogs, negative for L. infantum were enrolled in a multicentre, controlled study. Dogs were
divided into two homogeneous groups, defined as G1 (n = 102) and G2 (n = 117). Before the start of the sand fly
season, dogs in G1 were treated with the collar while animals in G2 were left untreated, serving as negative
controls. Dogs were serially sampled on day D90, D180, D210 and D300 in order to assess Leishmania infection by
IFAT, PCR on skin (D210-D300) and bone marrow (D300) and cytology on bone marrow aspirate (D300).
Results: Three dogs (2.9%) in G1 and 41 (40.2%) in G2 became positive for L. infantum in at least one of the
diagnostic tests employed in the study. The number of seropositive dogs in G2 increased in the course of the study
from 15 (D90) to 41 (D300), with some of them also positive in other diagnostic tests. Eight (19.6%) of the
seropositive dogs in G2 showed an increase in antibody titers ranging from 1:160 to 1:1,280. At the last follow-up,
some of dogs in G2 displayed overt clinical signs suggestive of leishmaniosis. The mean incidence density rate at
the final follow-up was 4.0% for G1 and 60.7% for G2, leading to a mean efficacy of the collar in protecting dogs at
both sites of 93.4%.
Conclusions: The slow-release collar tested in this study was shown to be safe and highly effective in preventing
L. infantum infection in a large population of dogs. Protection conferred by a single collar (up to eight months)
spanned an entire sand fly season in a hyper-endemic area of southern Italy. The regular use of collars, at least during
the sand fly season, may represent a reliable and sustainable strategy for the prevention of leishmaniosis in dogs living
in or travelling to an endemic area.
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Figure 1 Landscape of the Messina shelter (site S1) in which
approximately 450 dogs were housed.
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Canine leishmaniosis (CanL), caused by protozoa of the
genus Leishmania (Kinetoplastida: Trypanosomatidae),
occurs globally and is transmitted through the bites
of phlebotomine sand flies (Diptera: Psychodidae) [1].
Leishmania infantum is the most important aetiological
agent of CanL, and responsible for visceral and cutane-
ous leishmaniosis in humans in Eurasia and America
[2], with an estimated 8.5/100,000 new cases per year
in southern European countries (including Turkey)
[3,4]. Over the past two decades, the disease has spread
northwards from southern Europe [2,5] as a result of
several factors such as changes in the distribution of
phlebotomine sand fly vectors [6], increased movement
of dogs from Mediterranean to central and northern
regions [7], and lack of effective control measures [3,8].
Dogs act as reservoir hosts, and the association be-
tween CanL and human leishmaniosis has been proven
in areas where sand flies are present [1-3]. In particular,
dogs with overt clinical signs act as the most important
reservoir of L. infantum and play a major role in the epi-
demiology of the infection [9-11]. Therefore, although
anti-Leishmania treatment of infected dogs reduces
clinical signs and parasite load, it does not completely
inhibit infection by sand flies [12].
Over the last few decades, several attempts have been
made to improve control strategies and to develop reli-
able and cost-effective preventive measures in dogs [13].
For example, newly developed vaccines have shown effi-
cacy in preventing the progression of active infection
and disease [14-17]. Nonetheless, the prevention of sand
fly bites through the use of repellent and insecticidal
compounds in different formulations (e.g. spot-on, spray,
impregnated collars) is regarded as the most effective
method of avoiding L. infantum infection in dogs
[1,10,13] and therefore potentially reducing the risk for
human infection [18]. Several pyrethroid-based com-
pounds have been shown to be effective against Leish-
mania infection in dogs living in endemic areas [19-23].
Recently, a polymer matrix collar containing a combin-
ation of 10% imidacloprid and 4.5% flumethrin (Seresto®,
Bayer Animal Health), referred to in the following as
the “collar”, has been licensed for use in dogs and cats
[24]. This collar conferred long-term protection (eighth
months) against ticks and fleas [25,26] and was successful
in preventing the transmission of tick-borne pathogens
[27-29]. Although the collar is not currently registered
against sand flies, a single preliminary field trial showed
its potential for the control of CanL in young dogs from
an endemic area [30]. Thus, this study investigates the
efficacy of the collar in the prevention of infection by
L. infantum in dogs of different ages living in two heav-
ily populated shelters located in a hyper-endemic area
of the Mediterranean basin.Methods
Ethical statement
A negative-controlled and multicentre study was con-
ducted according to the principles of Good Clinical Prac-
tice (VICH GL9 GCP, 2000 http://www.ema.europa.eu/
docs/en_GB/document_library/Scientific_guideline/2009/
10/WC500004343.pdf) and the guideline on Statistical
Principles for Veterinary Clinical Trials (VICH CVMP/
816/00, 2000 http://www.ema.europa.eu/docs/en_GB/doc-
ument_library/Scientific_guideline/2012/01/WC500120834.
pdf). The study design and the experimental procedures
were approved and authorized by the Italian Ministry of
Health (authorization number DGSAF/297-03/04/2012).
Study sites
Dogs were housed in two private animal shelters in Sicily
(southern Italy), i.e. Messina (N 38.241624°E 15.522016°
altitude 520 m), and Augusta (N 37.239034°E 15.135016°
altitude 394 m), referred to as site 1 (S1) and site 2 (S2), re-
spectively. The study sites were located in a hyper-endemic
area for L. infantum [2,5], where the presence of competent
sand fly vectors was reported [31,32]. At site S1 approxi-
mately 450 dogs were housed in 124 pens measuring 18.4
or 54 m2 (Figure 1). Study dogs were housed in pens with
a concrete or mixed (concrete and fine gravel) floor, with
the pens separated by aluminum composite mesh
panels. Site 2 housed approximately 530 dogs in 38
mixed-floor pens each measuring about 100 m2. Pens in
S2 were separated by iron wire mesh (1×1 cm). In both
facilities all the dogs had an adequate covered resting
area with dog beds and an open area outside. Dogs in
each pen had daily access to wide, shared runs, and
were fed with commercial dry dog food and tap water.
Study design and experimental procedures
In March 2012, before enrolment, a total of 455 dogs
(S1 = 144, S2 = 311) were screened for circulating anti-
L. infantum antibodies using an indirect immunofluores-
cent antibody test (IFAT) and/or a rapid ELISA test (see
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as candidates for inclusion in the study. In April-May
2012 (Day 0) these animals were physically examined
and weighed, and blood, skin and bone marrow samples
were collected (see below). Dogs fulfilling the inclusion
criteria (normal general health, ≥ 7 weeks of age, not
treated with ectoparasiticidal products or immunosup-
pressive drugs in the preceding months, and negative for
L. infantum at serology (IFAT) and in skin and bone
marrow PCR and cytology on bone marrow smears from
samples collected at the time of inclusion) were enrolled
in the study. Included dogs were identified using the
microchip code and assigned to one of the two groups,
G1 and G2, using a random treatment allocation plan.
Randomization was conducted pen-wise instead of allo-
cating single dogs in order to avoid animals from both
groups being in physical contact in one pen and active
ingredient possibly being transferred from treated to
untreated dogs. On the day of inclusion (D0) imidaclo-
prid 10% + flumethrin 4.5% collars were fitted to dogs
in G1 on the basis of their body weight (i.e., small collar:
< 8 kg/large collar: > 8 kg), while dogs in G2 were left
untreated and served as negative controls.
Animals were followed up on days 90, 180, 210 and
300 after inclusion. At each follow-up dogs were physic-
ally examined and blood, skin and bone marrow samples
were collected as shown in Table 1. The collars were
worn from day 0 to 210 and were replaced only if they
were lost or if the animal’s weight increased above the
threshold of 8 kg. On day 210 the collars were removed
from the dogs in group G1 and not replaced. All dogs
included in the study were observed daily for any
changes in their health. The use of other ectoparasiti-
cides on dogs or in the environment was not allowed
throughout the study period. However, individual treat-
ments were authorized when heavy tick or flea infesta-
tions occurred. Due to the nature of the investigational
veterinary product (collar), blinding was applicable only
for the personnel that performed laboratory analyses.
Sampling and diagnostic procedures
Blood samples of approximately 5 mL were collected in
vacuum tubes from the brachial or jugular vein, imme-
diately transferred into cooled storage (+4°C), left toTable 1 Study calendar and samples collected at the schedule
Study day Date Physical ex
Preliminary Screening March-April 2012 +
Inclusion (D0) April-May 2012 +
I Follow-up (D90 ± 10) July-August 2012 +
II Follow-up (D180 ± 10) October-November 2012 +
III Follow-up (D210 ± 10) November-December 2012 +
IV Follow-up (D300 ± 10) February-March 2013 +clot, and centrifuged (1,700 rpm for 10 minutes). The
resulting serum was collected in individual microtubes.
Skin tissue samples (about 0.5 cm2) were collected
from the interscapular region and stored in individual
microtubes containing 1 mL of phosphate buffer saline
(PBS) solution. Bone marrow was sampled by an aspir-
ation technique from the iliac crest using Rosenthal
needles (16 or 18 gauge) and stored in the same way as
blood and skin samples. In addition, bone marrow samples
were smeared on slides for cytological examination for
L. infantum amastigotes. Microtubes containing sera, skin
and bone marrow samples were stored at −20°C until
analysis.
Serum samples were tested for circulating anti-
L. infantum antibodies by IFAT using a cut-off of 1:80
as described elsewhere [23]. Positive sera were also
titrated using serial dilutions until negative. In addition, in
order to reduce the risk of enrolling potentially infected
dogs, serum samples collected at the preliminary
screening were tested using 1:40 as cut-off. PCR for
the amplification of Leishmania DNA was performed on
bone marrow and skin samples. Total DNA was extracted
using the QIAampDNA Micro Kit (Qiagen, GmbH,
Hilden, Germany) and the Genomic DNA Purification
Kit (Gentra Systems, Minnesota, USA), respectively,
and a fragment of L. infantum kinetoplast DNA mini-
circle was amplified using the MC1/MC2 primer set
[33]. Amplicons were resolved in ethidium bromide-
stained (2%) agarose gels (Gellyphor, Italy) and sized
by comparison with markers in the Gene Ruler™ 100 bp
DNA Ladder (MBI Fermentas, Lithuania). Gels were
photographed using a digital documentation system
(Gel Doc 2000, BioRad, UK). Bone marrow smears were
stained with MGG Quick Stain (Bio-Optica, Italy) and
microscopically examined for L. infantum amastigotes.
Each smear was examined for about 10 minutes under
light microscopy (100 microscopic fields) using a 100×
oil immersion objective.
Entomological survey of sand fly activity
Light traps were used to assess the species and activity of
sand flies in the investigated shelters. Starting from May
2012, two traps were placed biweekly in each shelter 50
cm above the ground before sunset (6:00 p.m.) and leftd visits from screened/included dogs
amination Collar Blood Skin Bone marrow
- + - -
Application + + +
- + - -
- + - -
Removal + + -
- + + +
Table 2 Results of screening for the presence of
circulating anti-Leishmania infantum antibodies
Study site
Messina (S1) Augusta (S2)
Number of screened animals 144 311
Mean age (months)/range 48.5/3-108 38.1/2-120
Coat length (%) short/medium/long 50.0/35.4/14.6 52.7/35.6/11.7
Sex (%) female/male 52.8/47.2 60.8/39.2
ELISA Positive 15/144 (10.4%) 33/311 (10.6%)
IFAT Positive 11/50 (22.0%) 69/268 (25.7%)
ELISA and/or IFAT positive 21/144 (14.6%) 79/311 (25.4%)
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was suspended after three consecutive negative trap-
pings. Sand flies captured and grouped by shelter and
collection day were counted and the species were iden-
tified using morphological keys [34,35].
Statistical analysis
The minimum sample size per group (n = 107), was
determined by Win-Episcope 2.0 [36] based on an
expected incidence of 1% and 10% in G1 and G2,
respectively (power = 90% and confidence level = 95%).
The homogeneity of the groups was calculated retro-
spectively on day 0 baseline characteristics such as sex,
age, coat length and body weight using a Chi-square test
or Fisher’s exact test for qualitative data (sex, coat length)
and analysis of variance (ANOVA) for quantitative data
(age and weight). Since the objective of the study was
to define the efficacy of the treatment in preventing
L. infantum infection, negative dogs were defined as
those that were negative in any of the diagnostic tests
used (IFAT, PCR of skin and bone marrow tissues,
cytology of bone marrow aspirate) throughout the
study. The efficacy evaluation was based on the com-
parison of the incidence of L. infantum-infected dogs
in the two treatment groups. Incidence was calculated as
the annual crude incidence (i.e. considering only the re-
sults of the final sampling regardless of what happened
in between) as follows: annual crude incidence = num-
ber of dogs newly infected with L. infantum/(number of
negative dogs initially enrolled − number of lost or dead
dogs) × 100. To overcome the problem of dogs lost to
follow-up during the study, the incidence of infection
was also calculated using the incidence density rate
(IDR) [37]. IDRs were calculated at each follow-up as
the number of newly infected dogs in any diagnostic
test, divided by the number of dog-months of follow-up
(i.e. the number of months between the previous and the
current assessment for each dog at risk for L. infantum
infection). Dogs tested only once (e.g. lost, dead) did
not contribute at any time to the incidence calculation.
Final IDRs were then expressed per year.
The efficacy (%) of the collar in preventing L. infantum
infection was calculated using the formula: % protection =
(% of positive dogs in group G2 - % of positive dogs in
group G1)/(% of positive dogs in group G2) × 100. The
percentage of positive dogs was calculated as the IDR.
The significance of the efficacy (i.e. the significance
of the difference between IDRs in collared and non-
collared dogs) was tested using the Chi-square test.
Results
At the preliminary screening 355 (78%) out of 455
dogs tested serologically negative for circulating anti-
L. infantum antibodies (Table 2). The percentage ofseropositive dogs was higher (p > 0.05) in S2 (25.4%;
79/311) than in S1 (14.6%; 21/144). On Day 0, 279
(G1 = 135, G2 = 144) dogs were enrolled; however, 60
dogs (G1 = 33, G2 = 27) were excluded from the study
because they were either positive to serology and/or
PCR on samples collected at day 0 (G1 = 26, G2 = 22),
reluctant to keep the collar (G1 = 3), given for adop-
tion (G2 = 1), dead before first follow-up visit (G1 = 2,
G2 = 4) or because a history of leishmaniosis was
reported (G1 = 2). Thus, a total of 219 (G1 = 102, G2 = 117)
dogs were kept in the study and included in the calculation
of efficacy. These dogs were homogeneously distributed
(p > 0.05) with respect to sex, coat length, age and
weight (Table 3). In the course of the study, 29 (G1 = 16,
G2 = 13) were lost to follow-up at different time-points
due to a fatal outcome of aggression (fights) (G1 = 11,
G2 = 12), renal failure (G2 = 1), or they were excluded
because they lost the collar more than 3 times (G1 = 5).
In treated animals, collars were replaced if the dog’s
weight increased above the 8 kg threshold (n = 8), or
because they were damaged or lost on one (n = 10) or
more (n = 3) occasions.
Overall, three dogs (2.9%) in G1 and 47 (40.2%) in G2
tested positive for L. infantum in at least one of the diag-
nostic tests employed in the study. The number of sero-
positive dogs in G2 increased in the course of the study
from 15 (first follow-up) to 41 (fourth follow-up), with
some of them (n = 19; 40.4%) also positive in PCR on
skin and/or bone marrow and/or in cytology on bone
marrow aspirate (Table 4). All dogs except for one that
had an initial seroconversion remained positive until the
end of the study. Eight of the seropositive dogs (19.6%)
in G2 showed an increase in antibody titers ranging
from 1:160 to 1:1,280. Of the seropositive dogs in G1,
two were found to be positive since the second follow-
up, while the third tested serologically positive at the last
follow-up (Table 4). At the last follow-up, some of the
positive dogs in G2 displayed overt clinical signs sug-
gestive of CanL, with lymph node enlargement (n = 28;
Table 3 Characteristics of dogs included in the study
All sites Messina (S1) Augusta (S2)
G1 G2 Total G1 G2 G1 G2
Number of included dogs 102 117 219 35 38 67 79
Mean age (months)/range 30.7/2-96 29.5/2-84 30.1/2-96 29.9/3-84 31.3/3-72 31.1/2-96 28.6/2-84
Sex (%) female/male 55.9/44.1 65.0/35.0 60.7/39.3 60.0/40.0 52.6/47.4 53.7/46.3 70.9/29.1
Weight (kg)/range 19.3/3.8-41 19.2/4.1-47 19.3/3.8-41 19.6/7.5-41 21.5/6.9-47 19.2/3.8-35 18.1/4.1-38
Coat length (%)
Short 55.8 53.0 54.3 51.5 50.0 58.2 54.4
Medium 32.3 35.0 33.8 28.5 36.8 34.3 34.1
Long 11.9 12.0 11.9 20.0 13.2 7.5 11.5
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the most frequent signs (Figure 2).
The annual crude incidence calculated using dogs that
remained in the study until the last scheduled follow-up
(D300) was 3.5% (3/86) and 39.4% (41/104) for G1 and
G2, respectively (p < 0.001). The IDRs for each group at
each follow-up are shown in Table 5. The mean IDR at
the final follow-up was 4.0% for G1 and 60.7% for G2.
Hence, the mean efficacy of the collar in protecting dogs
from L. infantum infection was 93.4% (p < 0.01), ranging
from 90.5% to 100% at site S2 and S1, respectively. No
adverse events or side effects related to the collars
were observed in treated dogs. Severe tick infestations
were recorded in 38 dogs in G2; these animals were
individually treated by manual removal (n = 17) or
with non-repellent individual ectoparasiticide product,
i.e. Frontline® spot-on, Merial SAS (n = 21).
Sand flies (n = 700) were captured from the end of
May 2012 until the first week of November 2012 (S1),
and from the end of June until October (S2). At both
sites Sergentomyia minuta was the best-represented
species (433 females and 83 males; 73.7%), followed by
Phlebotomus perniciosus (84 males and 35 females; 16.9%),
Phlebotomus perfiliewi (42 females and 13 males; 7.9%)
and Phlebotomus neglectus (7 females and 2 males; 1.3%).
A single female specimen of Phlebotomus sergenti was
captured at site S2. The largest number (n = 327) of sand
flies was captured in September, while the majority of
P. perniciosus specimens were collected in August (n = 21),
September (n = 40) and October (n = 25), respectively.
Discussion
The slow-release collar tested in this study proved to be
safe and highly effective (mean efficacy at the final
follow-up = 93.4%) in preventing L. infantum infection
in dogs living in an area hyper-endemic for CanL. A sin-
gle preliminary field trial suggested the high potential of
this collar in preventing CanL in young dogs never
exposed to a transmission season [30]. In the present
study we confirmed and extended this knowledge bytesting the collar in a larger and heterogeneous dog
population from an area hyper-endemic for CanL. The
hyperendemicity of both study sites was confirmed by
the annual incidence (39.4%) and the mean IDR
(60.7%) recorded in the control dogs at the last follow-
up, which are the highest ever recorded in southern
Italy [19-21,23,30,38-40]. This might be due to the
simultaneous presence of diseased animals and suscep-
tible unprotected dogs in the two shelters, along with
the presence of competent sand fly species. In addition,
according to the results of the preliminary screening, a
large number of apparently healthy but seropositive
dogs were present at both study sites (S1 = 14.6%; 21/
144 and S2 = 25.4%; 79/311).
In the course of the study, a total of 47 (40.2%) out of
the 117 uncollared dogs tested positive at least in one
of the four follow-up investigations. The majority of
these dogs were positive only on serology while others
(n = 19/47; 40.4%) displayed an active infection, being
simultaneously positive by different diagnostic methods
(serology, PCR and cytology). The status of active infec-
tion was also corroborated by the increase in the antibody
titers recorded in eight dogs (19.6%). It is known that,
once established in dogs, L. infantum infection progresses
over a variable period of time through different clinical
presentations [7,38,40], although in the 12 months post
infection the majority of dogs do not display a clinical
condition [40]. Accordingly, in the present study, while
lymph-node enlargement was the clinical sign most fre-
quently found (68.3%) in serologically positive dogs,
other signs such as dry exfoliative dermatitis and weight
loss were observed at the last follow-up in 14.6% and
2.4% of dogs, respectively.
Among the collared dogs, only three animals became
seropositive for L. infantum. Although seropositive, these
animals did not show clinical signs suggestive of CanL.
These three dogs were housed at site S2, where the highest
IDR of the infection (63.9%) in control dogs was registered
at the last follow-up. This might explain the high parasitic
pressure at site S2, which ultimately led to a percentage of
Table 4 Results of diagnostic tests recorded in the follow-up of dogs in both groups (G1 = treated and G2 = control) that became positive for Leishmania
infantum in at least one test/follow-up
Group ID/
Site
I Follow-up (July-Aug. 2012) II Follow-up (October-Nov. 2012) III Follow-up (November- Dec. 2012) IV Follow-up (February-March 2013)
Serology Serology Serology PCR skin Serology PCR skin PCR bone marrow Cytology
G1 042/S2 negative negative negative negative 1:80 negative negative negative
G1 261/S2 negative 1:80 1:160 negative 1:160 negative negative positive
G1 310/S2 negative 1:80 1:320 negative 1:320 negative negative positive
G2 073/S2 1:80 1:80 1:80 negative 1:80 negative negative negative
G2 081/S2 negative negative 1:80 negative 1:80 positive negative positive
G2 083/S2 1:80 - - - - - - -
G2 086/S2 negative 1:80 1:80 negative 1:80 negative positive positive
G2 092/S2 negative 1:80 negative negative negative negative negative negative
G2 093/S2 negative negative 1:80 negative 1:80 negative negative positive
G2 106/S2 negative negative 1:80 negative 1:80 negative negative positive
G2 109/S2 1:80 1:80 1:80 negative 1:80 positive negative negative
G2 111/S2 negative negative 1:80 negative 1:80 negative negative positive
G2 112/S2 negative negative 1:80 negative 1:80 positive negative positive
G2 140/S2 1:80 1:80 1:80 negative 1:80 positive negative positive
G2 142/S2 1:80 - - - - - - -
G2 157/S2 1:80 - - - - - - -
G2 158/S2 1:80 1:80 1:160 positive 1:1,280 positive negative negative
G2 163/S2 negative negative 1:80 positive 1:160 positive negative negative
G2 164/S2 negative negative 1:80 negative 1:80 negative negative negative
G2 168/S2 negative negative negative negative 1:80 positive negative negative
G2 173/S2 1:80 1:80 1:80 negative 1:80 negative negative negative
G2 175/S2 negative negative 1:80 negative - - - -
G2 177/S2 negative negative 1:80 negative 1:80 negative negative negative
G2 178/S2 negative negative negative negative 1:80 negative negative negative
G2 179/S2 negative negative 1:80 negative 1:160 negative negative positive
G2 192/S2 negative negative 1:80 negative 1:80 negative negative negative
G2 201/S2 negative negative 1:80 positive 1:160 negative positive negative
G2 204/S2 1:80 1:80 1:80 negative 1:80 negative negative negative
G2 208/S2 1:80 1:80 1:80 negative 1:80 positive negative negative
G2 216/S2 1:80 1:80 1:80 negative 1:80 negative negative negative















Table 4 Results of diagnostic tests recorded in the follow-up of dogs in both groups (G1 = treated and G2 = control) that became positive for Leishmania
infantum in at least one test/follow-up (Continued)
G2 272/S2 1:80 1:80 1:160 negative 1:160 negative negative negative
G2 273/S2 1:80 1:80 1:160 negative - - - -
G2 277/S2 negative negative 1:80 negative 1:80 negative negative negative
G2 298/S2 negative negative 1:80 negative 1:80 negative negative negative
G2 018/S1 negative negative 1:80 negative 1:80 negative negative negative
G2 021/S1 negative negative 1:80 negative 1:80 negative negative negative
G2 022/S1 negative negative 1:160 positive 1:160 negative negative negative
G2 051/S1 negative negative 1:80 negative 1:80 negative negative negative
G2 062/S1 negative negative negative negative 1:80 negative negative negative
G2 063/S1 negative negative 1:80 negative 1:80 negative negative negative
G2 064/S1 negative negative 1:80 negative 1:80 negative negative negative
G2 065/S1 negative negative 1:80 negative 1:80 negative negative positive
G2 087/S1 1:80 1:80 1:80 negative 1:80 negative negative positive
G2 100/S1 negative negative 1:80 negative 1:80 negative negative negative
G2 101/S1 negative negative negative negative 1:80 negative negative negative
G2 139/S1 1:80 1:160 1:320 negative 1:320 negative negative negative
G2 140/S1 negative negative negative negative 1:80 negative negative negative
G2 143/S1 negative negative 1:160 positive 1:320 positive negative negative
G2 144/S1 negative negative 1:80 negative 1:80 positive negative negative















Figure 2 A control dog showing clinical signs of leishmaniosis
(i.e. dry exfoliative dermatitis) at the last follow-up (D300).
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through which the collar protects dogs against Leishmania
infection is the anti-feeding effect of flumethrin that
reduces the number of sand flies bites and, in turn, the
infection challenge [30]. In the same way, it has been
demonstrated that a small number of sand flies may
effectively feed on collared dogs, as demonstrated in a
study with dogs wearing deltamethrin-impregnated
collars [41]. Nonetheless, most sand flies fed on col-
lared dogs will die in a few hours [41]. Thus, it may be
concluded that even if some collared dogs may become
infected if bitten by an infected sand fly, they will
hardly ever contribute to transmission of the infection
to other dogs. Indeed, most sand flies will be repelled
when in contact with a collared dog and the few that
will be able to feed on them will die shortly afterwards.
The percentage efficacy of the collar containing imida-
cloprid (10%) and flumethrin (4.5%) against L. infantum
infection recorded in young dogs (100%) [30] or in the
present study (93.4%) is higher than that obtained
using a deltamethrin-impregnated collar, which yielded
a maximum 86% after two consecutive seasons in
southern Italy [19,20]. This might be due to the longer
residual effect of the imidacloprid/flumethrin collarTable 5 Incidence density rate for leishmaniosis in collared (G
follow-up in the study
Study day Number of dogs in the cohort Number of new cases









Inclusion (D0) 102 (35/67) 117 (38/79) - -
I Follow-up
(D90 ± 10)
102 (35/67) 117 (38/79) 0 (0/0) 15 (2/13)
II Follow-up
(D180 ± 10)
91 (30/61) 100 (36/64) 2 (0/2) 2 (0/2)
III Follow-up
(D210 ± 10)
86 (30/56) 95 (36/59) 0 (0/0) 25 (10/15)
IV Follow-up
(D300 ± 10)
84 (30/54) 67 (26/41) 1 (0/1) 5 (3/2)
Total 3 47 (15/32) 8
Site S1 =Messina shelter; Site S2 = Augusta shelter.(up to 8 months) than the deltamethrin collar (up to 5
months) as a result of the slow-release mechanism of
the first device. In the present study, treated dogs wore
the collar for up to eight months (from May to December).
Accordingly, sand fly species that are competent vectors
of L. infantum (P. perniciosus, P. perfiliewi and P.
neglectus) were captured from June to October and
from May to November at sites S1 and S2, respectively.
The retrieval of a single specimen of P. sergenti in S2 is
also of interest considering that this species is involved in
the transmission of Leishmania tropica, the aetiological
agent of human cutaneous leishmaniosis in the Middle
East and Africa [2].
Despite the protracted period for which the collars
were worn and the typology of the treated animals, i.e.
sheltered dogs living in collective pens separated by iron
wire meshes, no side effects or accidents were recorded
during the study. The percentage (22.5%) of collar re-
placements observed in this study is similar to that re-
ported in a previous investigation involving the same
collar [30]. In fact, the dogs that had lost the collar were
mainly young, probably very playful and lively animals.
Conclusions
The slow-release collar containing a combination of 10%
imidacloprid and 4.5% flumethrin tested in this study
proved to be safe and highly effective (90.5–100%) in
preventing L. infantum infection in a large and heteroge-
neous group of dogs. The labeled protection conferred
by a single collar (eight months) spanned an entire sand
fly season in the examined area, where competent sand
flies are active from May to November. Therefore, the
regular use of collars, at least during the sand fly season,
may be regarded as a reliable and sustainable strategy
for the control of leishmaniosis in dogs living in or trav-
elling to an area endemic for CanL.1) and uncollared control (G2) dogs calculated for each
Dog-months of follow-up Incidence density rate/year









- - - -
299.9 (97.7/202.3) 341.6 (103.4/238.6) 0.0 (0.0/0.0) 52.7 (23.2/65.4)
273.9 (91.8/182.4) 308.0 (115.9/192.0) 8.8 (0.0/13.2) 7.8 (0.0/12.6)
81.7 (29.1/52.1) 89.30 (34.9/55.5) 0.0 (0.0/0.0) 336.0 (343.6/324.6)
242.8 (87.0/155.5) 190.3 (75.4/115.2) 4.9 (0.0/7.7) 31.5 (47.8/20.8)
98.3 (305.6/592.3) 929.2 (329.6/601.3) 4.0 (0.0/6.1) 60.7 (54.6/63.9)
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